ADX-102

CAS No. 916056-79-6

ADX-102 ( Reproxalap;NS-2 )

Catalog No. M16578 CAS No. 916056-79-6

ADX-102 (Reproxalap, NS-2) is a novel small molecule immunomodulator that covalently binds aldehydes including malondialdehyde and 4-hydroxynonenal.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 In Stock
5MG 72 In Stock
10MG 102 In Stock
25MG 205 In Stock
50MG 290 In Stock
100MG 484 In Stock
500MG 1035 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ADX-102
  • Note
    Research use only, not for human use.
  • Brief Description
    ADX-102 (Reproxalap, NS-2) is a novel small molecule immunomodulator that covalently binds aldehydes including malondialdehyde and 4-hydroxynonenal.
  • Description
    ADX-102 (Reproxalap, NS-2) is a novel small molecule immunomodulator that covalently binds aldehydes including malondialdehyde and 4-hydroxynonenal, which have been shown to mediate inflammatory pain; DX-102 is a promising agent for the treatment of dry eye disease.Allergy Phase 3 Clinical
  • Synonyms
    Reproxalap;NS-2
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Other Targets
  • Research Area
    Inflammation/Immunology
  • Indication
    Allergy

Chemical Information

  • CAS Number
    916056-79-6
  • Formula Weight
    236.70
  • Molecular Formula
    C12H13ClN2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(C)(C)C1=NC2=CC=C(Cl)C=C2C=C1N
  • Chemical Name
    2-(3-amino-6-chloroquinolin-2-yl)propan-2-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Giganteone C

    The herbs of Curcuma wenyujin Y.H.Chen & C.Ling.

  • CCP peptide

    CCP peptide is a synthetic cyclic peptide incorporating the amino acid citrulline.

  • ICI-118551 Hydrochlo...

    ICI-118551 is a highly selective β2-adrenergic receptor antagonist with Ki values of 0.7, 49.5 and 611 nM for β2, β1 and β3 receptors, respectively.